Summary
Introduction
Immunodeficiency diseases are often complicated with a variety of comorbid conditions, mostly infections and less common hematologic disorders, autoimmune diseases, and malignancy, but rarely heart disease.
Case report
We describe the case of a 24-year-old male with hyper-IgE syndrome (HIES) diagnosed at 4 years of age, with documented mutation in signal transducer and activator of transcription 3 (STAT3). He had been closely followed for management of various infections and other complications (table 1). He had almost all typical manifestations of the disease (1) including total serum IgE as high as > 100,000 IU/mL, severe eczema, retention of primary teeth, recurrent Staphylococcal aureus and fungal skin infections, as well as the typical facial features including prominent forehead, deep set eyes, broad nasal bridge, wide nasal tip, and mild prognathism. Over the years, he suffered major complications including severe scoliosis, osteoporosis, multiple bone admission to the hospital, his symptoms were compatible with acute decompensated heart failure. He had no recent viral illness or previous heart disease. Physical examination was notable for tachycardia (120-130 beats/min), tachypnea (18-27 breaths/min), elevated jugular venous pressure to the jaw angle, pulmonary crackles bilaterally, and S3 gallop.
fractures, and chronic skin infection on the chest caused by Fusarium falciforme resistant to multiple antifungals and requiring resection. He also had staphylococcal lung abscess that required partial resection of the left upper lobe. At age 24, he developed fatigue, dyspnea on exertion, orthopnea, and mild right sided pleuritic chest pain. Upon However, his cardiac function did not improve and he had frequent hospital admissions for heart failure. Within 24 hours of his last admission, the patient became acutely dyspneic, cyanotic, and subsequently collapsed. He developed severe hypotension and pulseless electrical activity arrest. Bedside echocardiogram was negative for pericardial effusion. Resuscitation was attempted but all efforts were unsuccessful. The family did not consent for autopsy.
Discussion
Hyperimmunoglobulin E syndrome (HIES) is extremely rare with an estimated prevalence of 1 in 100,000 individuals (2). The condition was initially called "Job's syndrome," based upon a description of the biblical story on Job in the Old Testament "so went Satan forth from the presence of the Lord, and smote Job with sore boils from the sole of his foot unto his crown" (Job 2:7). HIES can be autosomal dominant or autosomal recessive. The majority of patients have the autosomal dominant (AD-HIES) form with an underlying STAT3 gene defect (3, 4) . In addition to eczema, AD-HIES is associated with high susceptibility to staphylococcal and fungal infections and defective dentition, skeletal, and connective tissues. The autosomal recessive form is not associated with skeletal or dental involvement but can have severe viral infections, marked eosinophilia, and severe neurologic complications (5). In some patients, the connective tissue defect can lead to cardiac disease such as coronary arteries tortuosity, vascular ectasia, focal aneurysms, and pseudoaneurysms (6,7). In animal experiments, cardiac myocyte-specific STAT3 deficiency in mice leads to cardiomyopathy with early cardiac failure (8) . However, to the best of our knowledge, neither cardiomyopathy nor myocarditis has been reported in patients with HIES, except for a presumptive diagnosis of myocarditis in a 2-year-old child that was not specified by a biopsy (9) . In our patient, lymphocytic myocarditis was biopsy-diagnosed and did not seem to be secondary to infection. The biopsy did not show significant eosinophils and the patient's circulating eosinophil count was not different from those during the previous years. Initially, the cardiac dysfunction seemed to improve on corticosteroids in addition to appropriate treatment of heart Electrocardiogram showed sinus tachycardia with diffuse ST segment elevations. Laboratory findings included elevated serum troponin I at 6.3 ng/mL (normal < 0.05 ng/mL) and brain natriuretic protein at 6353 pg/mL (normal 5-125 pg/ mL). He had mild anemia with Hgb level 12.1 g/dL (normal 12.5-16.3 g/dL), and elevated absolute eosinophil count of 1.43 K/μL (normal 0-0.5K/μL). His previous eosinophil levels during the past two years ranged from 0.29 to 1.53 K/μL and mostly were less than 1.0 K/μL. Two-dimensional echocardiogram revealed global hypokinesis of left ventricle with estimated ejection fraction 20-25%. On day two of the hospital admission, he developed episodes of sinus node pauses and left heart catheterization revealed ectasia of multiple coronary arteries. To rule out giant cell myocarditis, endomyocardial biopsy of the right ventricle was performed. It showed lymphocytic myocarditis, eosinophils in some blood vessel walls, focal necrosis, mild fibrosis, and myxoid degeneration (figure 1). The biopsy cultures were negative. Laboratory evaluation did not reveal infectious etiology, including HSV, parvovirus, CMV, EBV, Borrelia, HIV, or hepatitis. Methylprednisolone (1 mg/kg daily) was administered for two days followed by a 2-week prednisone taper. The patient improved and was given an external defibrillator (life vest) on discharge with plan to repeat echocardiogram after three months of heart failure therapy. Six weeks after discharge, the patient was re-admitted due to lightheadedness and palpitations. He admitted poor compliance with wearing the cardiac monitor. Electrocardiogram was consistent with supraventricular tachycardia. Echocar- failure including beta blockers, spironolactone, furosemide, ACE-inhibitors, and fluid restriction. Immunosuppressants were not considered because of their high risk in such patients. IVIG has been used, as an immunomodulatory therapy in a few scattered cases of acute myocarditis, presumably viral-induced, with good outcomes (10, 11, 12) . However, a recent Cochrane review concluded that more studies are needed before IVIG is routinely recommended for myocarditis (13). When our patient was readmitted, IVIG was administered in a modest dose (400 mg/kg) to avoid circulation overload on top of his heart failure. He showed some improvement that permitted his discharge from the hospital. It was repeated in the clinic every four weeks and he received a total of four doses. Unfortunately, his cardiac condition deteriorated and he died despite standard treatment of heart failure. Normally, transcription factor STAT1 has a proapoptotic effect and STAT3 has a protective effect on cardiac myocytes by antagonizing STAT1, and thus protecting against ischemia / reperfusion (14). Therefore, STAT3 mutation, as in our patient, could be a risk factor for myocarditis.
Conclusions
We report a biopsy-proven lymphocytic myocarditis as a complication of HIES in a young adult who was maintained in a relatively satisfactory clinical condition from early childhood in spite of multiple complications. Both immunologists and cardiologists should be aware of such a complication. Also, caution is required in considering the use of immunosuppressants when the immune status is markedly compromised. More data is needed on the dosage and potential benefit of using IVIG in myocarditis. To the best of our knowledge, this is the first reported case of HIES complicated with lymphocytic myocarditis.
